NCT05819203View on ClinicalTrials.gov

BАbykids Spray In Common Cold

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
Common ColdRhinitis Viral
Interventions
DEVICE

Healsea Babykids

7-day-treatment period (14 intakes ) up to 10 days (20 intakes) .

DEVICE

Placebo

7-day-treatment period (14 intakes ) up to 10 days (20 intakes) .

Trial Locations (3)

Unknown

Medical center, Plovdiv

Medical center, Sofia

Medical center, Vratsa

Sponsors
All Listed Sponsors
lead

Lallemand Pharma AG

INDUSTRY

NCT05819203 - BАbykids Spray In Common Cold | Biotech Hunter | Biotech Hunter